Molecular basis of RanGTP-activated release of Histones H2A-H2B from Importin-9
Structure · 2023
DOI: 10.1016/j.str.2023.06.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Structure, 2023. Verfasst von Joy M Shaffer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson 75080, USA. Hauptthemen laut MEDLINE: Histones, Nucleosomes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIGMS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson 75080, USA.
- Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas 75390, USA.
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson 75080, USA. Electronic address: sheena.darcy@utdallas.edu.
Förderung
- NIGMS NIH HHS
- NIGMS
- National Institutes of Health
- Welch Foundation
- National Science Foundation
Zitieren
APA
Shaffer, J. M., Jiou, J., Tripathi, K., Olaluwoye, O. S., Fung, H. Y. J., Chook, Y. M., & D'Arcy, S. (2023). Molecular basis of RanGTP-activated release of Histones H2A-H2B from Importin-9. Structure. https://doi.org/10.1016/j.str.2023.06.001
Vancouver
Shaffer JM, Jiou J, Tripathi K, Olaluwoye OS, Fung HYJ, Chook YM, et al. Molecular basis of RanGTP-activated release of Histones H2A-H2B from Importin-9. Structure. 2023. doi:10.1016/j.str.2023.06.001
BibTeX
@article{Shaffer2023,
author = {Shaffer, Joy M and Jiou, Jenny and Tripathi, Kiran and Olaluwoye, Oladimeji S and Fung, Ho Yee Joyce and Chook, Yuh Min and D'Arcy, Sheena},
title = {Molecular basis of RanGTP-activated release of Histones H2A-H2B from Importin-9},
journal = {Structure},
year = {2023},
doi = {10.1016/j.str.2023.06.001}
}
EUVIMED